Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
106.3 USD | -0.90% | -1.32% | -3.54% |
04-29 | Abbott's Dissolving Stent Gets FDA Approval For Arteries Below the Knee | MT |
04-26 | Dexcom's profit beats estimates on strong glucose monitor demand | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.54% | 186B | |
-2.29% | 107B | |
-3.98% | 67.44B | |
+2.82% | 50.03B | |
+16.12% | 47.81B | |
+4.79% | 41.03B | |
+1.56% | 26.85B | |
+2.96% | 25.82B | |
-0.40% | 25.01B | |
+16.55% | 24.74B |
- Stock Market
- Equities
- ABT Stock
- News Abbott Laboratories
- Abbott Laboratories : Fulfills US Government's Order of 150 Million BinaxNOW COVID-19 Rapid Tests